Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Cerebral venous thrombosis and its hemorrhagic complications

https://doi.org/10.14412/2074-2711-2021-2-10-18

Full Text:

Abstract

 Cerebral sinus thrombosis or cerebral venous thrombosis (CVT) is an important cause of nontraumatic intracranial hemorrhage in younger patients. CVT is associated with multiple risk factors and clinical conditions, is often undetected or verified late, and most importantly, has a relatively good prognosis if the treatment is started early. In this review, we describe CVT epidemiology and risk  factors, analyze its pathophysiology and clinical symptoms and  discuss modern diagnostic approaches to diagnosis, treatment and  secondary prevention. The article emphasizes the hemorrhagic  presentations of CVT, which in clinical settings are difficult to  diagnose and treat. 

About the Author

A. A. Kulesh
E.A. Wagner Perm State Medical University, Ministry of Health of Russia
Russian Federation

Russia, 614590, Perm, 26 Petropavlovskaya St. 



References

1. Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep. 2019 Aug 23;19(10):74. doi: 10.1007/s11910-019-0988-x

2. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2012 Dec;43(12):3375-7. doi: 10.1161/STROKEAHA.112.671453. Epub 2012 Sep 20.

3. Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke. 2016;47(9):2180-2. doi: 10.1161/STROKEAHA.116.013617

4. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356-67. doi: 10.1136/practneurol-2019-002415

5. Coutinho JM, Zuurbier SM, Stam J. Declining mortality in cerebral venous thrombosis: a systematic review. Stroke. 2014;45(2014):1338-41. doi: 10.1161/STROKEAHA.113.004666

6. Green M, Styles T, Russell T, et al. Non-genetic and genetic risk factors for adult cerebral venous thrombosis. Thromb Res. 2018;169:15-22. doi: 10.1016/j.thromres.2018.07.005

7. Ferro JM, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664-70. doi: 10.1161/01.STR.0000117571.76197.26

8. Afifi K, Bellanger G, Buyck PJ, et al. Features of intracranial hemorrhage in cerebral venous thrombosis. J Neurol. 2020;267(11):3292-8. doi: 10.1007/s00415-020-10008-0

9. Mowla A, Shakibajahromi B, Shahjouei S, et al. Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series. J Neurol Sci. 2020;419:117183. doi: 10.1016/j.jns.2020.117183

10. Klein DE, Libman R, Kirsch C, Arora R. Cerebral venous thrombosis: A typical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis. 2020;29(8):104989. doi: 10.1016/j.jstrokecerebrovasdis.2020.104989

11. Medicherla CB, Pauley RA, de Havenon A, et al. Cerebral Venous Sinus Thrombosis in the Coronavirus Disease 2019 Pandemic. J Neuroophthalmol. 2020. doi: 10.1097/WNO.0000000000001122

12. Pongmoragot J, Saposnik G. Intracerebral hemorrhage from cerebral venous thrombosis. Curr Atheroscler Rep. 2012;14(4):382-9. doi: 10.1007/s11883-012-0260-1

13. Sader N, de Lotbiniere-Bassett M, Tso MK, Hamilton M. Management of Venous Sinus Thrombosis. Neurosurg Clin N Am.

14. 2018;29(4):585-94. doi: 10.1016/j.nec.2018.06.011

15. Breteau G, Mounier-Vehier F, Godefroy O, et al. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol. 2003;250:29-35. doi: 10.1007/s00415-003-0932-4

16. Kumral E, Polat F, Uzunköprü C, et al. The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis. Eur J Neurol. 2012;19(4):537-43. doi: 10.1111/j.1468-1331.2011.03562.x

17. Girot M, Ferro JM, Canhao P, et al., ISCVT Investigators. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke. 2007;38:337-42. doi: 10.1161/01.STR.0000254579.16319.35

18. Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555-65. doi: 10.1038/nrneurol.2017.104

19. Duman T, Uluduz D, Midi I, et al. A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study. J Stroke Cerebrovasc Dis. 2017;26(8):1848-57. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.020

20. Garcia-Azorin D, Monje MHG, Gonzalez-Garcia N, et al. Presence of red flags in patients with cerebral venous sinus thrombosis admitted to the emergency department because of headache: A STROBE compliant cohort-study. Medicine (Baltimore). 2020;99(29):e20900. doi: 10.1097/MD.0000000000020900

21. Ferro JM, Canhao P, Bousser MG, et al. ISCVT Investigators. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke. 2008;39(4):1152-8. doi: 10.1161/STROKEAHA.107.487363

22. Mahale R, Mehta A, John AA, et al. Acute seizures in cerebral venous sinus thrombosis: what predicts it? Epilepsy Res. 2016;123(2016):1-5. doi: 10.1016/j.eplepsyres.2016.01.011

23. Uluduz D, Midi I, Duman T, et al. Epileptic seizures in cerebral venous sinus thrombosis: Subgroup analysis of VENOST study. Seizure. 2020;78:113-7. doi: 10.1016/j.seizure.2020.02.017

24. Kalita J, Misra UK, Singh VK, Dubey D. Predictors and outcome of status epilepticus in cerebral venous thrombosis. J Neurol. 2019;266(2):417-25. doi: 10.1007/s00415-018-9145-8

25. Sanchez van Kammen M, Lindgren E, Silvis SM, et al. Late seizures in cerebral venous thrombosis. Neurology. 2020;95(12):e1716-e1723. doi: 10.1212/WNL.0000000000010576

26. Kowoll CM, Kaminski J, Weiss V, et al. Severe cerebral venous and sinus thrombosis: clinical course, imaging correlates, and prognosis. Neurocrit Care. 2016;25(3):392-9. doi: 10.1007/s12028-016-0256-8

27. Barboza MA, Chiquete E, Arauz A, et al. A Practical Score for Prediction of Outcome After Cerebral Venous Thrombosis. Front Neurol. 2018;9:882. doi: 10.3389/fneur.2018.00882

28. Heldner MR, Zuurbier SM, Li B, et al. Prediction of cerebral venous thrombosis with a new clinical score and D-dimer levels. Neurology. 2020;95(7):e898-e909. doi: 10.1212/WNL.0000000000009998

29. Buyck PJ, de Keyzer F, Vanneste D, et al. CT density measurement and H:H ratio are useful in diagnosing acute cerebral venous sinus thrombosis. AJNR Am J Neuroradiol. 2013;34:1568-72. 2013 Aug;34(8):1568-72. doi: 10.3174/ajnr.A3469. Epub 2013 Mar 7.

30. Van Dam LF, van Walderveen MAA, Kroft LJM, et al. Current imaging modalities for diagnosing cerebral vein thrombosis – A critical review. Thromb Res. 2020;189:132-9. doi: 10.1016/j.thromres.2020.03.011

31. Canedo-Antelo M, Baleato-Gonzalez S, Mosqueira AJ, et al. Radiologic Clues to Cerebral Venous Thrombosis. Radiographics. 2019;39(6):1611-28. doi: 10.1148/rg.2019190015

32. Idbaih A, Boukobza M, Crassard I, et al. MRI of clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted images. Stroke. 2006 Apr;37(4):991-5. doi: 10.1161/01.STR.0000206282.85610.ae. Epub 2006 Feb 16.

33. Wasay M, Azeemuddin M. Neuroimaging of cerebral venous thrombosis. J Neuroimaging. 2005;15:118-28. doi: 10.1111/j.1552-6569.2005.tb00296.x

34. Rollins N, Ison C, Reyes T, Chia J. Cerebral MR venography in children: comparison of 2D time-of-flight and gadoliniumenhanced 3D gradient-echo techniques. Radiology. 2005 Jun;235(3):1011-7. doi: 10.1148/radiol.2353041427. Epub 2005 Apr 28.

35. Conforto AB, Nader SN, Puglia Junior P, et al. Dural arteriovenous fistula and cerebral venous thrombosis. Arq Neuropsiquiatr. 2015 Jun;73(6):548. doi: 10.1590/0004-282X20150050

36. Ferro JM, Bousser MG, Canhao P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology. Eur J Neurol. 2017 Oct;24(10):1203-13. doi: 10.1111/ene.13381. Epub 2017 Aug 20.

37. Salottolo K, Bartt R, Frei DF, et al. Timing of Anticoagulation in Patients with Cerebral Venous Thrombosis Requiring Decompressive Surgery: Systematic Review of the Literature and Case Series. World Neurosurg. 2020;137:408-14. doi: 10.1016/j.wneu.2020.02.084

38. Siddiqui FM, Dandapat S, Banerjee C, et al. Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases. Stroke. 2015 May;46(5):1263-8. doi: 10.1161/STROKEAHA.114.007465. Epub 2015 Apr 21.

39. Ilyas A, Chen C-J, Raper DM, et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review. J Neurointerv Surg. 2017 Nov;9(11):1086-1092. doi: 10.1136/neurintsurg-2016-012938. Epub 2017 Feb 17.

40. Coutinho JM, Zuurbier SM, Bousser MG, et al.; TO-ACT investigators. Effect of Endovascular Treatment With Medical

41. Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial. JAMA Neurol. 2020;77(8):966-73. doi: 10.1001/jamaneurol.2020.1022

42. Wang Y, Zhao C, Huang D, et al. Stent retriever thrombectomy combined with longterm local thrombolysis for severe hemorrhagic cerebral venous sinus thrombosis. Exp Ther Med. 2020 Nov;20(5):66. doi: 10.3892/etm.2020.9194. Epub 2020 Sep 9.

43. Ferro JM, Bousser MG, Canhao P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195-221. doi: 10.1177/2396987317719364

44. Geisbüsch C, Richter D, Herweh C, et al. Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients. Stroke. 2014 Aug;45(8):2469-71. doi: 10.1161/STROKEAHA.114.006167. Epub 2014 Jun 24.

45. Mendonca MD, Barbosa R, Cruz-E-Silva V, et al. Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients. Int J Stroke. 2015 Oct;10(7):1115-8. doi: 10.1111/ijs.12462. Epub 2015 Feb 24.

46. Ferro JM, Coutinho JM, Dentali F, et al. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. JAMA Neurol. 2019 Sep 3;76(12):1457-65. doi: 10.1001/jamaneurol.2019.2764. Online ahead of print.

47. Lee GKH, Chen VH, Tan CH, et al. Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis. J Thromb Thrombolysis. 2020;50(3):724-31. doi: 10.1007/s11239-020-02106-7

48. Lurkin A, Derex L, Fambrini A, et al. Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis. Cerebrovasc Dis. 2019;48(1-2):32-7. doi: 10.1159/000502454. Epub 2019 Sep 3.

49. Wasay M, Khan M, Rajput HM, et al. New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study. J Stroke. 2019 May;21(2):220-3. doi: 10.5853/jos.2019.00150. Epub 2019 May 31.

50. Herweh C, Griebe M, Geisbüsch C, et al. Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis. Eur J Neurol. 2016 Apr;23(4):681-7. doi: 10.1111/ene.12901. Epub 2015 Nov 19.

51. Wells J, Ehrlich M, Johansen M, et al. Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral Venous Sinus Thrombosis (CVST): a retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA. Neurology. 2019;92(15 Suppl).

52. Saposnik G, Barinagarrementeria F, Brown RD, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158-92. doi: 10.1161/STR.0b013e31820a8364

53. De Bruijn SF, Budde M, Teunisse S, et al. Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology. 2000;54:1687-9. doi: 10.1212/WNL.54.8.1687

54. Aguiar de Sousa D, Lucas Neto L, Canhao P, Ferro JM. Recanalization in Cerebral Venous Thrombosis. Stroke. 2018;49(8):1828-35. doi:10.1161/STROKEAHA.118.022129

55. Rezoagli E, Martinelli I, Poli D, et al. The effect of recanalization on long-term neurological outcome after cerebral venous thrombosis. J Thromb Haemost. 2018;16(4):718-24. doi: 10.1111/jth.13954

56. Aguiar de Sousa D, Lucas Neto L, Arauz A, et al. Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation. Stroke. 2020;51(4):1174-81. doi: 10.1161/STROKEAHA.119.028532

57. Arauz A, Vargas-Gonzalez JC, Arguelles-Morales N, et al. Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy. J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):247-51. doi.org/10.1136/jnnp-2014-310068. Epub 2015 Mar 23.


For citation:


Kulesh A.A. Cerebral venous thrombosis and its hemorrhagic complications. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(2):10-18. https://doi.org/10.14412/2074-2711-2021-2-10-18

Views: 144


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)